Matches in Nanopublications for { ?s ?p "[However, a significant fraction of patients with HER2+ breast cancer treated with these agents eventually relapse or develop progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP615077.RAFSfrMPt9LMl1bAMAJHCui9YRZrCp0Tjgiq9jcF5wn6o130_assertion description "[However, a significant fraction of patients with HER2+ breast cancer treated with these agents eventually relapse or develop progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615077.RAFSfrMPt9LMl1bAMAJHCui9YRZrCp0Tjgiq9jcF5wn6o130_provenance.
- NP379941.RApTQ3iQVXp6TD9AcVEX-Z8pqL1R7WSOqxIxXHg_eat6E130_assertion description "[However, a significant fraction of patients with HER2+ breast cancer treated with these agents eventually relapse or develop progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379941.RApTQ3iQVXp6TD9AcVEX-Z8pqL1R7WSOqxIxXHg_eat6E130_provenance.
- NP380573.RAjTLwnT4aEOJYzEW5HzkNQT47zHQnoVpKIYucTloOkPc130_assertion description "[However, a significant fraction of patients with HER2+ breast cancer treated with these agents eventually relapse or develop progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380573.RAjTLwnT4aEOJYzEW5HzkNQT47zHQnoVpKIYucTloOkPc130_provenance.
- NP972213.RAgu76pCoojy0VoCs_EmBlnxjMDWbNRhI2QdM42Y1Yfl0130_assertion description "[However, a significant fraction of patients with HER2+ breast cancer treated with these agents eventually relapse or develop progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP972213.RAgu76pCoojy0VoCs_EmBlnxjMDWbNRhI2QdM42Y1Yfl0130_provenance.
- NP972215.RApJj3AMNVbozy6BxetKWSCr-A3SuFOycF_2sypg4ENGs130_assertion description "[However, a significant fraction of patients with HER2+ breast cancer treated with these agents eventually relapse or develop progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP972215.RApJj3AMNVbozy6BxetKWSCr-A3SuFOycF_2sypg4ENGs130_provenance.
- NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_assertion description "[However, a significant fraction of patients with HER2+ breast cancer treated with these agents eventually relapse or develop progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP972214.RA41EAnEhqEjvwQupD8e0zF4l6DtwyjlxffSZda1qX7kM130_provenance.
- NP972216.RAx6hU94QhECnS4ewJ-g3J6dS0WwPeYdkeACLyshp5cXE130_assertion description "[However, a significant fraction of patients with HER2+ breast cancer treated with these agents eventually relapse or develop progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP972216.RAx6hU94QhECnS4ewJ-g3J6dS0WwPeYdkeACLyshp5cXE130_provenance.